Alibaba Unveils Qwen3.6-Plus AI Model and Leads RMB500m StairMed Funding
Alibaba launched its Qwen3.6-Plus AI model, offering stronger agentic and multimodal capabilities to integrate into enterprise workflows for coding, problem solving and mixed media tasks. Separately, Alibaba led a RMB500m ($72.7m) Series financing in StairMed Technology to advance clinical trials of its BMI and DBS systems in China.
1. AI Model Launch
Alibaba has rolled out Qwen3.6-Plus, its latest artificial intelligence model featuring enhanced agentic capabilities that allow it to autonomously solve developer tasks, write code and handle complex workflows. The update also boosts multimodal reasoning, enabling seamless processing of text, images and video to align AI output with real-world enterprise applications.
2. Investment in StairMed Technology
In a strategic move into biotech, Alibaba led a RMB500 million ($72.7 million) financing round for Shanghai-based StairMed Technology. The funding will support the acceleration of clinical programmes, including mid-2026 initiation of large-scale registration trials for its implantable brain-machine interface and planned 2027 trials for its closed-loop deep-brain stimulation system.